-
Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks.
Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH.
Prenat Diagn 2011;31:75-83. -
Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R, Pérez Penco JM, Skyfta E, Rodríguez Calvo J, Nicolaides KH.
Fetal Diagn Ther 2010;27:72-7. -
Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC, Chelemen T, Minekawa R, Frisova V, Nicolaides KH.
Am J Obstet Gynecol 2009;200:508.1-6. -
Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH.
Prenat Diagn 2009;29:1103-8. -
First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH.
Obstet Gynecol 2008;112:1082-90. -
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.
Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, Tal J, Cuckle HS.
Ultrasound Obstet Gynecol 2006;27:13-7. -
ADAM12-s in coelomic fluid and maternal serum in early pregnancy.
Makrydimas G, Sotiriadis A, Spencer K, Cowans NJ, Nicolaides KH.
Prenat Diagn 2006;26:1197-200.